Allstate (ALL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

06.02.25 02:00 Uhr

Werte in diesem Artikel
Aktien

188,70 EUR 3,95 EUR 2,14%

Indizes

PKT PKT

16.544,2 PKT 249,3 PKT 1,53%

5.676,1 PKT 37,2 PKT 0,66%

Allstate (ALL) reported $16.71 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 12.1%. EPS of $7.67 for the same period compares to $5.82 a year ago.The reported revenue represents a surprise of -0.01% over the Zacks Consensus Estimate of $16.71 billion. With the consensus EPS estimate being $6.51, the EPS surprise was +17.82%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Allstate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Combined Ratio - Property-liability: 86.9% compared to the 90.2% average estimate based on seven analysts. Expense Ratio - Property-liability: 23.2% versus 22% estimated by six analysts on average. Loss Ratio - Property-liability: 63.7% versus the six-analyst average estimate of 67.8%. Combined Ratio - Auto: 93.5% versus 93.2% estimated by six analysts on average. Property-Liability- Net Premiums Earned: $13.93 billion versus $14 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +10.6% change. Allstate Health and Benefits- Net Investment Income: $26 million versus the six-analyst average estimate of $25.87 million. The reported number represents a year-over-year change of +18.2%. Allstate Health and Benefits- Other Revenue: $144 million compared to the $129.41 million average estimate based on six analysts. The reported number represents a change of +2.1% year over year. Property-Liability- Other Revenue: $493 million compared to the $472.64 million average estimate based on six analysts. The reported number represents a change of +20.2% year over year. Corporate and Other- Net Investment Income: $24 million versus the six-analyst average estimate of $23.16 million. The reported number represents a year-over-year change of 0%. Allstate Health and Benefits- Accident and health insurance premiums and contract charges: $482 million versus the six-analyst average estimate of $479.81 million. The reported number represents a year-over-year change of +3.2%. Property-Liability- Net Investment Income: $757 million compared to the $683.89 million average estimate based on six analysts. The reported number represents a change of +40.7% year over year. Protection Services- Net Investment Income: $26 million versus the five-analyst average estimate of $24.41 million. The reported number represents a year-over-year change of +30%. View all Key Company Metrics for Allstate here>>>Shares of Allstate have returned +2.6% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Allstate Corporation (ALL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Allstate

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Allstate

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Allstate Corp.

Wer­bung

Analysen zu Allstate Corp.

DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
03.04.2017Allstate Mkt PerformFBR & Co.
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
04.08.2015Allstate OverweightBarclays Capital
DatumRatingAnalyst
03.04.2017Allstate Mkt PerformFBR & Co.
05.08.2015Allstate NeutralCompass Point
04.08.2015Allstate Sector PerformRBC Capital Markets
07.05.2015Allstate NeutralCompass Point
31.10.2014Allstate NeutralCompass Point
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Allstate Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen